Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome
Condition: Nephrotic Syndrome Intervention: Drug: ADX-629 Sponsor: Aldeyra Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2022 Category: Research Source Type: clinical trials
Part 1 - A Clinical Trial in Children and Adults With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome
Condition: Nephrotic Syndrome Intervention: Drug: ADX-629 Sponsor: Aldeyra Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2022 Category: Research Source Type: clinical trials
Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome
Condition: Nephrotic Syndrome Intervention: Drug: ADX-629 Sponsor: Aldeyra Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2022 Category: Research Source Type: clinical trials